July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Extended Delivery of Pirfenidone with Novel Soft Contact Lenses
Author Affiliations & Notes
  • Caiqing Wu
    Zhongshan Ophthalmic Center, GuangZhou, Guangdong, China
  • Ping Wai Or
    Department of Mechanical and Aerospace Engineering, The Hong Kong University of Science and Technology, Hong Kong
  • Jones Chong
    Department of Mechanical and Aerospace Engineering, The Hong Kong University of Science and Technology, Hong Kong
  • Xiaotao Chen
    Zhongshan Ophthalmic Center, GuangZhou, Guangdong, China
  • Ching Hymn Christopher Lee
    Department of Mechanical and Aerospace Engineering, The Hong Kong University of Science and Technology, Hong Kong
  • Isuru KK Pathirage Don
    Department of Mechanical and Aerospace Engineering, The Hong Kong University of Science and Technology, Hong Kong
  • Minbin Yu
    Zhongshan Ophthalmic Center, GuangZhou, Guangdong, China
  • David Lam
    Department of Mechanical and Aerospace Engineering, The Hong Kong University of Science and Technology, Hong Kong
  • Yangfan Yang
    Zhongshan Ophthalmic Center, GuangZhou, Guangdong, China
  • Footnotes
    Commercial Relationships   Caiqing Wu, None; Ping Wai Or, None; Jones Chong, None; Xiaotao Chen, None; Ching Hymn Christopher Lee, None; Isuru KK Pathirage Don, None; Minbin Yu, None; David Lam, None; Yangfan Yang, None
  • Footnotes
    Support  Guangzhou Science and Technology Project Grant 2016-55
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3804. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Caiqing Wu, Ping Wai Or, Jones Chong, Xiaotao Chen, Ching Hymn Christopher Lee, Isuru KK Pathirage Don, Minbin Yu, David Lam, Yangfan Yang; Extended Delivery of Pirfenidone with Novel Soft Contact Lenses. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3804. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A drug-loaded soft contact lens (SCL) for extended pirfenidone (PFD) delivery has been developed. The distribution over time and effects of sustained release were evaluated in rabbits.

Methods : A water-soluble insert, consisting of polyvinyl alcohol (PVA) and PFD, was embedded into a soft contact lens for extended delivery. Soft contact lenses were fitted to 4 New Zealand white rabbits weighing between 2.0kg to 2.5kg. The rabbits wore SCLs for 24 continuous hours while monitoring the irritation using the Draize score system. The safety of the SCL was evaluated on the eye surface performance by slit-lamp microscopic examination in vivo. Rabbit eyes were given new SCL containing 150ug of PFD and 0.5% PFD eye drops served as control, and PFD concentration were detected by high performance liquid chromatography (HPLC) in tears at different time points following the PFD loaded contact lens placed on the cornea of rabbits.

Results : Slit-lamp microscopic examination showed the novel designed SCL suits rabbits’ eyes well. Compared with eye drops, the drug-loaded contact lens increased the concentration of PFD in tears. PFD can be detected in tears up to 10 hours after following the PFD loaded contact lens placed on the cornea of rabbits. After wearing the SCL for consecutive 24h, no obvious irritation on rabbit eyes was observed and Draize scored 0.

Conclusions : The novel drug delivery contact lens showed significant improvement of the bioavailability of PFD while having no obvious toxicity and irritation on the rabbit eyes. A soft contact lens is an ideal delivery system for long-lasting effective retention of PFD, suggesting SCL would be an ideal carrier of PFD to realize the long-lasting effective retention on eyes.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×